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Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $4.00 per copy, plus US $00.20 per page, is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. Since the initial description of techniques to immortalize antibody-producing B-lymphocytes by fusion with tissue culture-adapted myeloma cells, methods have been developed to produce monoclonal antibodies of defined specificity in multiple animal species. Stable hybrids can be readily produced in mice using a number of myeloma and hybridoma cell lines. To obviate the problem of identifying fusion partners in other animal species, xenohybrids have been produced using B-lymphocytes from the relevant species and mouse myeloma cells. The use of xenohybrids has minimized the problem of obtaining stable antibody-producing hybrids in all species examined thus far. Although alternative techniques are being developed to produce monoclonal antibodies by molecular methods, hybridoma technology will remain the technology of choice for producing monoclonal antibodies for a variety of applications in research and industry.
The objective of Monoclonal Antibody Protocols is to provide investigators with a set of methods for producing and using monoclonal antibodies in biomedical, agricultural, and biological sciences. The book is not intended to provide methodology for all possible applications, but rather a series of methods presented in an easy-tofollow format that can be used by new and established investigators, graduate and postgraduate fellows, and technical staff. The methods include descriptions of techniques for immunization in vivo and in vitro to obtain the antibodies of interest; production of monoclonal antibodies in mice, humans, and domestic species; isotyping and characterizing antibodies; producing antibodies in a bioreactor to eliminate the need of using mice to produce immune ascites; purification of IgG and IgM antibodies; preparation of immunoaffinity columns; conjugation of antibodies with fluorophores, biotin, and enzymes; and also descriptions of popular applications such as the use of monoclonal antibodies in immunoaffinity purification of mol-ecules, Western blotting, and chemiluminescence, immunohistochemistry, electron microscopy, flow cytometry, and magnetic particle separation of leukocyte subpopulations.
Each chapter has been written by an author or authors with considerable experience in the use of the methodology. Where possible, an attempt has been made to introduce recent technological advances that facilitate the development and use of monoclonal antibodies. Each chapter starts with a brief description of the technique and application, followed by a detailed step-by-step outline of the methods. A notes section is included to provide additional information on problems that are occasionally encountered in the use of the technology and recommendations on how to identify the source of the problem and the steps needed to modify the procedures to obtain the expected results. Chapters are cross-referenced where related techniques are described to reduce redundancy and facilitate use of the methodology.
Monoclonal Antibody Protocols should prove effective as an easy-to-use laboratory manual for developing and using monoclonal antibodies.
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